Event snippet :
 

Aalto inside...

OUR PRODUCTS

To play, press and hold the enter key. To stop, release the enter key.

Aalto Bio Reagents

  • Founded in 1978

  • Market leader in the development of proteins and antibodies for new and emerging diseases eg. Chikungunya , Dengue , Zika , Sars , COVID-19 and VEEV virus
     

  • Custom manufacture of new recombinant antigens

  • Routine manufacture of bulk antigens and antibodies

  • Full raw material menu for chemiluminescence platforms

  • Europes largest provider of bulk disease state plasma for controls
     

  • Joined the Biosynth Group to form the biologics division in May 2022